Description
Available syringe size: (1 x *0 ml or 1 x *0 ml)
Macrolane VRF *0 is suitable for areas with less tissue support and
cover.
Macrolane is a hyaluronic acid-based product for body contouring
and breast enhancement. Macrolane provides instant and long lasting
results without the need for open surgery and therefore avoids some
of the consequences such as scarring. It is injected into the
breast in the sub-glandular level and subcutaneously for body
contouring. The Macrolane gel is based on Q-Med's unique and
patented NASHA™ technology.
What is NASHA gel?
NASHA gel is a crystal clear gel consisting of biotechnologically
derived hyaluronic acid that has been purified and stabilized. The
hyaluronic acid is of non-animal origin, thus removing any risk of
diseases transmitted by animals.
The hyaluronic acid is stabilized, i.e. minimally modified (~1%),
to form a stable three-dimensional network. The unique patented
NASHA technology gives a biologically degradable gel that has a
long durability in the body.
Duration of treatments
A single treatment with Macrolane can last up to *2 months. The
body slowly metabolizes the biocompatible Macrolane gel. If longer
lasting results are desired, re-treatments can be made to maintain
the aesthetic results.
What are possible side effects?
The most common side effect is slight soreness or swelling at the
injection site, as expected for injection treatment.
Non-prescription anti-inflammatory pills are usually sufficient to
relieve the discomfort.
Perioperative infections have been reported. The signs and symptoms
are usually increasing pain, redness and hardness affecting one
breast, with or without systemic symptoms such as fever. A number
of measures are recommended to minimize the potential risk for
infection. The use of prophylactic antibiotics should be
considered. It is important to ascertain that the patient does not
have any concurrent skin infections prior to treatment. The
procedure should be carried out in a clean environment with
thorough skin preparation and use of aseptic techniques.
Antibiotics treatment is best initiated after obtaining material
for microbiological investigations.
Sometimes a capsule around the implant becomes contracted. This can
happen with both traditional permanent implants as well as for
Macrolane. If a patient with a traditional permanent implant gets a
severe capsular contracture, commonly the implant has to be
surgically removed.
If capsules arise in patients with Macrolane implants, most can be
treated with closed capsulotomy (the breasts are manually
compressed by the physician). The breasts usually soften after this
treatment. Other options for treatment of capsules include gel
aspiration or puncture of the capsule using a cannula.
Sometimes the capsular contracture reoccurs.
For detailed information regarding side effects, please review the
Instructions for Use.
